Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis

Background: TP73 antisense RNA 1 (TP73-AS1), a newly discovered long non-coding RNA (lncRNA), has been reported to be upregulated in various kinds of tumors, and shows a variable influence on living quality and prognosis of patients. Thus, we conducted a meta-analysis to evaluate the overall prognos...

Full description

Bibliographic Details
Main Authors: Xiaoqing Wang, Kunpeng Shu, Zhifeng Wang, Degang Ding, Xing Li
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Electronic Journal of Biotechnology
Online Access:http://www.sciencedirect.com/science/article/pii/S0717345819300545
_version_ 1819126756976623616
author Xiaoqing Wang
Kunpeng Shu
Zhifeng Wang
Degang Ding
Xing Li
author_facet Xiaoqing Wang
Kunpeng Shu
Zhifeng Wang
Degang Ding
Xing Li
author_sort Xiaoqing Wang
collection DOAJ
description Background: TP73 antisense RNA 1 (TP73-AS1), a newly discovered long non-coding RNA (lncRNA), has been reported to be upregulated in various kinds of tumors, and shows a variable influence on living quality and prognosis of patients. Thus, we conducted a meta-analysis to evaluate the overall prognostic value of the lncRNA TP73-AS1 in cancer patients. Results: A systematic literature retrieval was carried out using the PubMed, Cochrane Library, EMBASE, and Web of Science databases. We calculated the pooled hazard ratio (HR) and odds ratio (OR) with 95% confidence intervals (CIs) to evaluate the association of TP73-AS1 expression with prognostic and clinicopathological parameters. A total of 15 studies including 1057 cancer patients were finally selected for the meta-analysis. The results demonstrated that high TP73-AS1 expression was significantly associated with shorter overall survival (OS) (HR = 1.97, 95% CI: 1.68–2.31, P < 0.001). According to a fixed-effects or random-effects model, elevated TP73-AS1 expression markedly predicted advanced clinical stage (OR = 3.30, 95% CI: 2.35–4.64, P < 0.001), larger tumor size (OR = 2.37, 95% CI: 1.75–3.22, P < 0.001), earlier lymph node metastasis (OR = 3.28, 95% CI: 1.59–6.76, P = 0.001), and distant metastasis (OR = 4.94, 95% CI: 2.61–9.37, P < 0.001). Conclusions: High lncRNA TP73-AS1 expression appears to be predictive of a worse OS and clinicopathologic features for patients with various types of malignant tumors. These results provide a basis for utilizing TP73-AS1 expression as an unfavorable indicator to predict survival outcomes.How to cite: Wang X, Shu K, Wang Z, et al. Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis. Electron J Biotechnol 2020;43. https://doi.org/10.1016/j.ejbt.2019.12.005. Keywords: Carcinoma, Human cancer, lncRNA, Long noncoding RNA, Meta-analysis, Prognosis, TP73 antisense RNA, Tumors
first_indexed 2024-12-22T08:01:06Z
format Article
id doaj.art-9c2645dd3062467a9779b8bf2af79f50
institution Directory Open Access Journal
issn 0717-3458
language English
last_indexed 2024-12-22T08:01:06Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Electronic Journal of Biotechnology
spelling doaj.art-9c2645dd3062467a9779b8bf2af79f502022-12-21T18:33:14ZengElsevierElectronic Journal of Biotechnology0717-34582020-01-01433240Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysisXiaoqing Wang0Kunpeng Shu1Zhifeng Wang2Degang Ding3Xing Li4Department of Urology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, ChinaDepartment of Urology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China; Department of Urology, People's Hospital of Henan University, Zhengzhou 450003, ChinaDepartment of Urology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China; Department of Urology, People's Hospital of Henan University, Zhengzhou 450003, ChinaDepartment of Urology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China; Department of Urology, People's Hospital of Henan University, Zhengzhou 450003, China; Corresponding authors.Department of Urology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China; Corresponding authors.Background: TP73 antisense RNA 1 (TP73-AS1), a newly discovered long non-coding RNA (lncRNA), has been reported to be upregulated in various kinds of tumors, and shows a variable influence on living quality and prognosis of patients. Thus, we conducted a meta-analysis to evaluate the overall prognostic value of the lncRNA TP73-AS1 in cancer patients. Results: A systematic literature retrieval was carried out using the PubMed, Cochrane Library, EMBASE, and Web of Science databases. We calculated the pooled hazard ratio (HR) and odds ratio (OR) with 95% confidence intervals (CIs) to evaluate the association of TP73-AS1 expression with prognostic and clinicopathological parameters. A total of 15 studies including 1057 cancer patients were finally selected for the meta-analysis. The results demonstrated that high TP73-AS1 expression was significantly associated with shorter overall survival (OS) (HR = 1.97, 95% CI: 1.68–2.31, P < 0.001). According to a fixed-effects or random-effects model, elevated TP73-AS1 expression markedly predicted advanced clinical stage (OR = 3.30, 95% CI: 2.35–4.64, P < 0.001), larger tumor size (OR = 2.37, 95% CI: 1.75–3.22, P < 0.001), earlier lymph node metastasis (OR = 3.28, 95% CI: 1.59–6.76, P = 0.001), and distant metastasis (OR = 4.94, 95% CI: 2.61–9.37, P < 0.001). Conclusions: High lncRNA TP73-AS1 expression appears to be predictive of a worse OS and clinicopathologic features for patients with various types of malignant tumors. These results provide a basis for utilizing TP73-AS1 expression as an unfavorable indicator to predict survival outcomes.How to cite: Wang X, Shu K, Wang Z, et al. Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis. Electron J Biotechnol 2020;43. https://doi.org/10.1016/j.ejbt.2019.12.005. Keywords: Carcinoma, Human cancer, lncRNA, Long noncoding RNA, Meta-analysis, Prognosis, TP73 antisense RNA, Tumorshttp://www.sciencedirect.com/science/article/pii/S0717345819300545
spellingShingle Xiaoqing Wang
Kunpeng Shu
Zhifeng Wang
Degang Ding
Xing Li
Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
Electronic Journal of Biotechnology
title Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
title_full Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
title_fullStr Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
title_full_unstemmed Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
title_short Prognostic value of long non-coding RNA TP73-AS1 expression in different types of cancer: A systematic review and meta-analysis
title_sort prognostic value of long non coding rna tp73 as1 expression in different types of cancer a systematic review and meta analysis
url http://www.sciencedirect.com/science/article/pii/S0717345819300545
work_keys_str_mv AT xiaoqingwang prognosticvalueoflongnoncodingrnatp73as1expressionindifferenttypesofcancerasystematicreviewandmetaanalysis
AT kunpengshu prognosticvalueoflongnoncodingrnatp73as1expressionindifferenttypesofcancerasystematicreviewandmetaanalysis
AT zhifengwang prognosticvalueoflongnoncodingrnatp73as1expressionindifferenttypesofcancerasystematicreviewandmetaanalysis
AT degangding prognosticvalueoflongnoncodingrnatp73as1expressionindifferenttypesofcancerasystematicreviewandmetaanalysis
AT xingli prognosticvalueoflongnoncodingrnatp73as1expressionindifferenttypesofcancerasystematicreviewandmetaanalysis